identification of genomic biomarkers of disease progression & survival in primary cns lymphoma
Published 1 year ago • 170 plays • Length 4:40Download video MP4
Download video MP3
Similar videos
-
5:36
mcl0208: identification of novel genomic prognostic factors
-
3:12
analyzing patterns of disease failure in patients with primary cns lymphoma
-
1:12
using biomarkers and genomics to inform treatment strategy in all
-
2:33
identifying novel biomarkers and advancing the classification system in cll
-
3:03
the evolution of treatment patterns and prognostic biomarkers in latin american cll patients
-
5:50
understanding biomarkers
-
5:29
accelerating lung cancer diagnoses through liquid biopsy
-
56:51
biopharm america 2015 presents biomarkers and precision medicine
-
4:47
btk degradation as a novel therapeutic strategy for relapsed cns lymphoma
-
2:32
tools and biomarkers being used for the diagnosis of bpdcn
-
2:49
assessing parameters and standardising biomarker detection in cll
-
0:45
difference between quality of life & patient-reported outcomes
-
1:32
the importance of cytogenetics and molecular profiling for accurate aml/mds diagnosis
-
18:21
non-bcr-abl1 molecular biomarkers of prognosis in cml
-
4:57
oncology biomarker development at genentech
-
1:01
practical considerations regarding genomic testing for molecular aberrations
-
7:52
biomarkers and imaging
-
1:57
predicting ici response in nsclc with a deep learning radiomic biomarker
-
46:33
understanding biomarker testing
-
2:09
dr. finn on finding a biomarker for patients with hcc
-
0:42
ctdna in clinical practice for melanoma